Back

T-wave alternans poorly prognostic in primary prophylactic ICD patients: A prospective EU-CERT-ICD study

28 August 2022 (09:00 - 09:10)
Organised by:
Congress Presentation Part of: Primary arrhythmia syndromes - Device treatment Device Treatment ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Ari Pelli

Medical Research Center Oulu, Oulu (Finland)

3 More presentations in this session

Presentation thumbnail
Three dimensional modelling of mutant Kir2.1 channel PIP2 interactions help stratify arrhythmia severity in Andersen Tawil syndrome type 1
Mrs L. Gutierrez (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Characteristics and prognosis of the catecholamine induced QT prolongation syndrome
Professor V. Probst (Nantes, FR)
Abstract Slides Video
Presentation thumbnail
Catecholaminergic polymorphic ventricular tachycardia: risk modulators in patients treated with beta-blockers
Doctor D. Kukavica (Pavia, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Primary arrhythmia syndromes - Device treatment

The Event

Event poster

ESC Congress 2022

28 August 2022 09:00 CET
You may be interested in
thumbnail
Congress Session
When to implant a primary prevention ICD in patients with structural heart disease: interpreting the 2022 SCD ventricular arrhythmia guidelines
thumbnail
Congress Presentation
The impact of desmosomal mutations on clinical features in arrhythmogenic cardiomyopathy: towards tailored arrhythmic risk stratification
thumbnail
Congress Session
Risk stratification in ventricular arrhythmias

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources